HEALTH● ELEVATED6d ago · Oct 7, 2026, 9:41 PM
Valneva falls as UK revokes marketing authorization for chikungunya vaccine
Seeking Alpha Tech · western europe
Valneva's stock declined after the UK revoked marketing authorization for its chikungunya vaccine. This regulatory decision impacts the availability of the vaccine and the company's market position.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH48m agoAndhra University students attend Heartfulness session on stress management and well-beingThe HinduHEALTH1h agoDRC Ebola outbreak passes 9,000 cases, including more than 4,000 deathsAfricanews [en]HEALTH2h agoPope Leo XIV has cancerous tumour removed from right lungAfricanews [en]HEALTH2h ago"The Pope has lung cancer!": reactions in the world's main mediaClarín